ArticleBone2025
Altered digit tip blastema differentiation and bone regeneration in skeletally mature Ts65Dn Down syndrome mice.
Article in Bone, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Researcher's guide to rodent models of Down syndrome: Recent insights and translational perspectives.STAR protocols · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Down syndrome (DS), the result of Trisomy 21 (T21), is associated with accelerated aging and impacts many organ systems across the lifespan, including the musculoskeletal system. Skeletal deficits such as low bone mineral density predispose the T21 population to skeletal injuries, especially as they age, and likely reduce their capacity to repair bone. Previous studies have demonstrated impaired secondary fracture healing in 4-month-old DS mice and diminished bone regeneration in young (2-months-old) DS mice. To investigate how bone regeneration is further impacted in skeletally mature (6-months-old) mice, terminal phalanx (P3) digit tip amputations were performed in a murine model of DS, Ts65Dn mice. The P3 regeneration cascade is characterized by an initial phase of bone degradation followed by intramembranous ossification to restore the amputated bone. These studies demonstrate that the bone regeneration anomalies observed in young Ts65Dn mice are exacerbated in skeletally mature mice, characterized by a complex dysregulation of bone resorption and formation genes. Collectively, skeletally mature Ts65Dn mice show fundamental in vivo deficits in progenitor cell differentiation, cell activity, cell proliferation, and alterations in gene expression associated with diminished regenerative outcomes. Importantly, these deficiencies in bone regeneration in skeletally mature Ts65Dn mice have implications to the adult T21 population as the last several decades have seen substantial increases in the average life span of T21 individuals. If the regenerative defects in Ts65Dn mice are recapitulated during bone healing in the T21 population, this could have profound consequences for this growing population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.